- Previous Close
148,700.00 - Open
150,100.00 - Bid 149,600.00 x --
- Ask 150,000.00 x --
- Day's Range
147,200.00 - 150,400.00 - 52 Week Range
99,800.00 - 208,000.00 - Volume
37,579 - Avg. Volume
114,469 - Market Cap (intraday)
1.692T - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 5, 2025 - Mar 20, 2025
- Forward Dividend & Yield 500.00 (0.38%)
- Ex-Dividend Date Dec 27, 2023
- 1y Target Est
188,315.80
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under the Ginsenology name; and fragrance under the Scenteritage brand, as well as hair care products. The company was formerly known as Miroto Korea and changed its name to Cosmax, Inc. in 1994. Cosmax, Inc. was founded in 1992 and is headquartered in Hwaseong-si, South Korea.
www.cosmax.com1,390
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 192820.KS
View MorePerformance Overview: 192820.KS
Trailing total returns as of 12/30/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 192820.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 192820.KS
View MoreValuation Measures
Market Cap
1.69T
Enterprise Value
2.18T
Trailing P/E
21.50
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.83
Price/Book (mrq)
3.82
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
9.56
Financial Highlights
Profitability and Income Statement
Profit Margin
3.69%
Return on Assets (ttm)
5.41%
Return on Equity (ttm)
13.06%
Revenue (ttm)
1.97T
Net Income Avi to Common (ttm)
72.86B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
333.52B
Total Debt/Equity (mrq)
138.37%
Levered Free Cash Flow (ttm)
151.23B